Moreover, upregulation of miR-23b levels in radioresistant PDAC leads to sensitization of tumor cells to radiotherapy [126], while enhancement of miR-29c regulates USP22 increases the sensitivity of pancreatic cancer cells to chemotherapy [129]. This evidence concerns the gene USP22 and pancreatic neoplasm.